Venthamarai chooranam & yoga for hyperlipidemia

Completed

• Conditions: Other hyperlipidemia,

• Registration Number: CTRI/2023/06/053504

Brief Summary

Hyperlipidemia is one among the lifestyle modification disorders Hyperlipidemia means an increase in total cholesterol level which forms the base for many diseases such as coronary heart disease stroke In the siddha concept it may be correlated to the *Athimetham*It is mainly due to lifestyle modification unhealthy eating habits less physical activity medical health disorder under any medication Hence considerably more patients of *Athimetham* have been recorded in the Ayothiyadoss pandithar hospital The Siddha polyherbal formulation *Venthamarai chooranam*is said to be cost effective and simple formulation Most of the ingredients of *venthamarai chooranam* have the antioxidant anti hypertensive and hypolipidemic activity Major causes for hyperlipidemia are sedentary lifestyle unhealthy eating habits stress and obesity The improvement in lipid profile with practice of yoga is due to increased hepatic lipase and lipoprotein lipase This would increase the uptake of triglycerides by adipose tissue and affect the lipoprotein metabolism Yogasanam plays an important role in the management of cholesterol levels So I hope *Venthamarai chooranam* and yogasanam will be effective in the treatment of *Athimetham* (Hyperlipidemia)

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-15
• Study Completion: 2024-07-10
• Last Update Posted: 2024-07-12

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients satisfying any one of the following criteria Serum total cholesterol (above 200mg/dl) Serum triglycerides (above 150mg/dl) Low density lipoprotein (above 100mg/dl) Patients who are willing to provide blood for investigation before and after treatment Patient willing to sign in the consent form Patients who are willing to attend OPD once in 7 days.

Exclusion Criteria

Chronic renal failure Liver disorder Pregnancy and lactation Drug induced obesity Cardiac vascular disease Malignancy Neurological disease.

Study & Design

• Study Type: PMS
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The outcome of the study will be assessed by reduction in the lipid levels after treatment	The outcome of the study will be assessed by a reduction in lipid levels after 90 days of treatment

Trial Locations

Locations (1)

National Institute of Siddha; 🇮🇳 Chennai, TAMIL NADU, India

National Institute of Siddha

🇮🇳Chennai, TAMIL NADU, India

Dr S Swathi

Principal investigator

9655135040

bsmsswathi12@gmail.com